Glycomine is developing orphan drugs for serious rare monogenic disorders of metabolism and protein misfolding for which no other therapeutic options exist.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Peter McWilliams

Chief Medical Officer

Horacio Plotkin

Vice President

Geoffrey Hird

VP - Regulatory Affairs

Lisa Koch-Hulle

Browse more venture capital transactions:

Prev: 6/24/2021: Atom Finance venture capital transaction
Next: 6/24/2021: Tomi.ai venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary